AML (Acute Myeloid Leukemia),Leukemia Improved Outcomes With 131I-Apamistamab in TP53-Mutant AML Jun 19, 2024
AML (Acute Myeloid Leukemia),Leukemia Predicting AML Outcomes With Lysosome-Related Gene Profiles Jun 18, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia Pirtobrutinib Shows Promise in BTKi Naïve CLL/SLL: BRUIN Study Jun 14, 2024
CLL (Chronic Lymphocytic Leukemia),DLBCL (Diffuse Large B Cell Lymphoma),Leukemia,Lymphoma Epcoritamab Shows Promise in RT: EPCORE CLL-1 Trial Jun 13, 2024
CLL (Chronic Lymphocytic Leukemia),Leukemia Real-World Acalabrutinib: High RW-PFS & Continuation Rates Jun 13, 2024
AML (Acute Myeloid Leukemia),Leukemia Fraxetin: Multitarget Inhibition for AML Cell Control Jun 12, 2024
